Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Sclerochoroidal Calcification Is Primarily a Scleral Condition Based on Enhanced Depth Imaging Optical Coherence Tomography

Sclerochoroidal Calcification Is Primarily a Scleral Condition Based on Enhanced Depth Imaging... Letters 1. John GT, Manivannan J, Chandy S, et al. A prospective evaluation of macular edema, thought to be immune recovery uveitis in the leflunomide therapy for cytomegalovirus disease in renal transplant recipients. absence of CMV retinitis. She was treated with topical steroid Transplant Proc. 2005;37(10):4303-4305. eyedrops twice daily, an increased prednisone dosage to 60 2. Waldman WJ, Knight DA, Lurain NS, et al. Novel mechanism of inhibition of mg/d, and an increased leflunomide dosage to 60 mg/d. cytomegalovirus by the experimental immunosuppressive agent leflunomide. In April 2007, she developed an acute decrease in visual Transplantation. 1999;68(6):814-825. acuity of the right eye without floaters or pain. Her visual acu- 3. Avery RK, Mossad SB, Poggio E, et al. Utility of leflunomide in the treatment of complex cytomegalovirus syndromes. Transplantation. 2010;90(4):419-426. ity without correction was 20/200 OD. Optical coherence to- mography demonstrated an increase in macular edema on the 4. Levi ME, Mandava N, Chan LK, Weinberg A, Olson JL. Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered right. The leflunomide dosage was increased to 80 mg/d and leflunomide. Transpl Infect Dis. 2006;8(1):38-43. eventually 100 mg/d without improvement in macular edema, 5. Kuo IC, Imai Y, Shum C, Martin DF, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Sclerochoroidal Calcification Is Primarily a Scleral Condition Based on Enhanced Depth Imaging Optical Coherence Tomography

Loading next page...
 
/lp/american-medical-association/sclerochoroidal-calcification-is-primarily-a-scleral-condition-based-TdC1345A20
Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/jamaophthalmol.2013.67
Publisher site
See Article on Publisher Site

Abstract

Letters 1. John GT, Manivannan J, Chandy S, et al. A prospective evaluation of macular edema, thought to be immune recovery uveitis in the leflunomide therapy for cytomegalovirus disease in renal transplant recipients. absence of CMV retinitis. She was treated with topical steroid Transplant Proc. 2005;37(10):4303-4305. eyedrops twice daily, an increased prednisone dosage to 60 2. Waldman WJ, Knight DA, Lurain NS, et al. Novel mechanism of inhibition of mg/d, and an increased leflunomide dosage to 60 mg/d. cytomegalovirus by the experimental immunosuppressive agent leflunomide. In April 2007, she developed an acute decrease in visual Transplantation. 1999;68(6):814-825. acuity of the right eye without floaters or pain. Her visual acu- 3. Avery RK, Mossad SB, Poggio E, et al. Utility of leflunomide in the treatment of complex cytomegalovirus syndromes. Transplantation. 2010;90(4):419-426. ity without correction was 20/200 OD. Optical coherence to- mography demonstrated an increase in macular edema on the 4. Levi ME, Mandava N, Chan LK, Weinberg A, Olson JL. Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered right. The leflunomide dosage was increased to 80 mg/d and leflunomide. Transpl Infect Dis. 2006;8(1):38-43. eventually 100 mg/d without improvement in macular edema, 5. Kuo IC, Imai Y, Shum C, Martin DF,

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Jul 1, 2013

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month